|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| C07K 16/26 | (2006.01) | ||
| A61K2039/54 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K 16/18 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K 16/26 | (2013.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 25/04 | (2018.01) | ||
| A61P 25/06 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3318272 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17201603.2 |
| Date of filing the European patent application | 2011-06-07 | |
| (97) | Date of publication of the European application | 2018-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 353323 P | 2010-06-10 | US |
| (72) |
ALLAN, Barrett , US
BENSCHOP, Robert Jan , US
CHAMBERS, Mark Geoffrey , US
DARLING, Ryan James , US
|
| (73) |
ELI LILLY AND COMPANY ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | CGRP ANTIBODIES |
| CGRP ANTIBODIES |